Shanxi Zhendong Pharmaceutical Co (SZSE:300158) Change In Receivables : ¥0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Shanxi Zhendong Pharmaceutical Co Change In Receivables?

Shanxi Zhendong Pharmaceutical Co's change in receivables for the quarter that ended in Mar. 2024 was ¥0 Mil. It means Shanxi Zhendong Pharmaceutical Co's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

Shanxi Zhendong Pharmaceutical Co's change in receivables for the fiscal year that ended in Dec. 2023 was ¥98 Mil. It means Shanxi Zhendong Pharmaceutical Co's Accounts Receivable declined by ¥98 Mil from Dec. 2022 to Dec. 2023 .

Shanxi Zhendong Pharmaceutical Co's Accounts Receivable for the quarter that ended in Mar. 2024 was ¥645 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Shanxi Zhendong Pharmaceutical Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 75.28.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Shanxi Zhendong Pharmaceutical Co's liquidation value for the three months ended in Mar. 2024 was ¥2,213 Mil.

Shanxi Zhendong Pharmaceutical Co Change In Receivables Historical Data

The historical data trend for Shanxi Zhendong Pharmaceutical Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanxi Zhendong Pharmaceutical Co Change In Receivables Chart

Shanxi Zhendong Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-127.90

-202.15

303.08

319.57

97.98

Shanxi Zhendong Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Shanxi Zhendong Pharmaceutical Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

Shanxi Zhendong Pharmaceutical Co (SZSE:300158) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Shanxi Zhendong Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	645.269	/	782.13	*	91
=	75.28

2. In Ben Graham's calculation of liquidation value, Shanxi Zhendong Pharmaceutical Co's accounts receivable are only considered to be worth 75% of book value:

Shanxi Zhendong Pharmaceutical Co's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	2066.431	-	902.257	+	0.75 * 645.269	+	0.5 * 1130.531
=	2,213

Shanxi Zhendong Pharmaceutical Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Shanxi Zhendong Pharmaceutical Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanxi Zhendong Pharmaceutical Co (SZSE:300158) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanxi Zhendong Pharmaceutical Co Ltd (SZSE:300158) » Definitions » Change In Receivables

Traded in Other Exchanges

N/A

Address

Zhendong Technology Park, Guang Road, Changzhi County, Changzhi, CHN, SXI 047100

Website

http://en.zdjt.com

Shanxi Zhendong Pharmaceutical Co Ltd together with its subsidiaries, researches, develops, manufactures, and markets pharmaceutical products and Chinese medicines in China. It offers anticancer drugs, cardiovascular disease prevention and control drugs and anti-infection drugs among others. The company categorizes its product as Chinese & Western Medicine, Wuhe Food, Home Care Products and Traditional Chinese Medicine.

Executives

Miao Hui	Director
Ma Shi Feng	Executives
Li Zhi Xu	Executives
Li Xi Hai	Director
You Rong Li	Executives
Wang Xu Wen	Executives
Dong Mi Zhu	Directors, executives
Li Ren Hu	Supervisors
Ning Lu Hong	Directors, executives
Wang Li Qing	Supervisors
Jin Zhi Xiang	Supervisors

Shanxi Zhendong Pharmaceutical Co (SZSE:300158) Headlines

No Headlines